bioRxiv ScienceSearch

bioRxiv · 10.1101/543694

Designing synthetic bacterial consortia for landfill leachate treatment based on community matrices and regression tree analysis

Abstract

The performance of microbial communities exploited by industry are largely optimised by manipulating process parameters, such as flow rates, growth conditions, and reactor parameters. Conversely, the composition of microorganisms used are often viewed as a "black box". This is mostly due to the relatively high costs and technical expertise required to identify and quantify the microbial consortia, as well as limited tools to create functional assemblages. Unknown details about the interactions among species may impose a limit on how much microbial function can be optimised for industrial purposes. Here, a new workflow was developed for studying microbial consortia using high throughput, species and community specific measurements of growth rates and yields. Growth rate and yield among all single, pairwise, triple, quadruples, quintuple and sextuple combinations of six bacterial isolates on landfill leachate were evaluated. Additive, antagonistic (e.g. competitive) or synergistic (+/-) interactions can be inferred from the rate and yield data. We found that antagonistic interactions, which hinder growth and yield, were the dominant interaction type, with only a few synergistic interactions observed. Mixed effects models were used to investigate the relationship between interaction type and species richness (biodiversity). Community identity was found to be a more important factor in predicting yield determining interactions but not rate determining interactions. Species richness was a good predictor of rate determining interactions, with the most positive interactions happening at a low species richness. Regression tree analysis identified Lysinibacillus sp. as a keystone species, a genus previously associated with bioremediation. Its presence led to a drastic change in the function of the synthetic ecosystem, with both positive yield and rate determining interactions. We were able to infer interactions about specific pairs of species, and the competitive/synergistic tendencies of single species from only basic top-down growth measurements. In this way, we have demonstrated how factorial experiments using isolated microorganisms can be used to ultimately design synthetic consortia with desirable traits for industry. Funding statementThis research was funded by the EPSRC (Vacation Bursary Award), BBSRC (Impact Acceleration Award), Department of Chemical and Biological Engineering, The University of Sheffield (Summer Undergraduate Research Fellowship) and Viridor Ltd. Ethics statements(Authors are required to state the ethical considerations of their study in the manuscript, including for cases where the study was exempt from ethical approval procedures) Does the study presented in the manuscript involve human or animal subjects: No Data availability statementGenerated Statement: This manuscript contains previously unpublished data. The name of the repository and accession number are not available.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Hardo, G., Karunakaran, E., Couto, N., Beckerman, A., Pandhal, J.. 2019-02-08. Designing synthetic bacterial consortia for landfill leachate treatment based on community matrices and regression tree analysis. https://doi.org/10.1101/543694

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

A conserved cysteine-histidine-glutamate metal site identifies DUF501 (Rv1025), an essential uncharacterised protein family of Mycobacterium tuberculosis, as a candidate metalloenzyme and drug target

A substantial fraction of the Mycobacterium tuberculosis proteome remains functionally uncharacterised. Rv1025, a 155-residue protein carrying the domain of unknown function DUF501 (Pfam PF04417), is essential by transposon mutagenesis and vulnerable by CRISPR interference, an attractive but neglected drug target, yet has never been functionally described. The family (4,370 proteins, no Gene Ontology term, no solved structure) is uncharacterised across all organisms and essential in three Actinobacterial genera. A Foldseek search of the AlphaFold model against complete structural databases finds no significant homolog, indicating a novel fold. The operon eno-divIC-Rv1025-ppx2 is conserved across the Actinobacteria phylum, yet AlphaFold-Multimer finds no direct complex between Rv1025 and its neighbour DivIC. Instead, conservation across 8,700 homologous sequences reveals a near-invariant Cys113-His115-Glu59 cluster forming a pocket. Holo AlphaFold3 predictions with Zn, Fe and Mn confidently place a divalent metal on this triad at 2.25-2.47 A; mutating the triad relocates the metal, and an independent backbone-geometry predictor recovers the same site, confirming specificity. The triad is universal across the family: present in all 1,472 near-complete bacterial sequences of the Pfam alignment, with no non-conservative substitution among the 2,228 sequences examined, a defining feature of bacterial DUF501 rather than a mycobacterial peculiarity. We propose that DUF501 is a metal-binding protein and candidate metalloenzyme, the first functional hypothesis for this family, whose conserved, essential metal pocket is a promising drug target. As the predictions build on a conservation-defined site within a fully computational study, they are supportive rather than proof of metal occupancy and warrant experimental validation.

microbiology

Mycoplasmal endosymbionts of Trichomonas vaginalis are associated with reduced risk for Chlamydia trachomatis endometrial infection in asymptomatic, coinfected, women.

Trichomonas vaginalis is a protozoan parasite that causes trichomoniasis, the most common curable non-viral sexually transmitted infection, and Chlamydia trachomatis is a bacterial pathogen that can ascend to the upper genital tract and cause pelvic inflammatory disease, infertility, and ectopic pregnancy. T. vaginalis harbors bacterial endosymbionts, including Candidatus Malacoplasma girerdii, an obligate symbiont, and Metamycoplasma hominis, which can live freely or symbiotically. In a 16S rRNA sequencing study of the cervicovaginal microbiome of women at high risk for chlamydial infection, Ca. M. girerdii abundance was one of 13 features predicting lack of chlamydial spread to the endometrium, despite no direct association between T. vaginalis infection and reduced chlamydial ascension. Investigating the relationship between these microorganisms further, we found that T. vaginalis vaginal abundance correlated positively with chlamydial burden in women whose infection was confined to the cervix, while a nonsignificant inverse relationship was seen in women with endometrial spread. Among participants with high chlamydial burden, Ca. M. girerdii was detected exclusively in women without endometrial infection. Both endosymbionts trended toward more frequent detection, and higher abundance, in coinfected women without endometrial spread, while M. hominis abundance correlated strongly with T. vaginalis burden in this group. These findings suggest that mycoplasmal endosymbionts of T. vaginalis, rather than T. vaginalis itself, are microbial factors limiting chlamydial ascension, and point to a three-way interaction between parasite, endosymbiont, and bacterial pathogen that shapes upper genital tract C. trachomatis infection risk.

microbiology

Understanding the physiological alterations of Vibrio cholerae upon exposure to L-ascorbic acid

The scourge of cholera remains a major global public health threat. It affects up to 4 million people worldwide and causes tens of thousands of deaths each year. The disease is experiencing a concerning resurgence in many parts of Africa, the Middle East, and Asia. To effectively tackle cholera and circumvent rising antimicrobial resistance, targeted biological and preventive approaches, complementing traditional rehydration, are urgently needed. In this regard, our group has demonstrated the efficacy of L-ascorbic acid in controlling the growth and pathogenesis of Vibrio cholerae in vitro. The present work further provides a mechanistic elucidation of the L-ascorbic acid-mediated physiological changes in V. cholerae and also bolsters such a non-antibiotic approach to control cholera.

microbiology